⌕
Axogen · AXGN · Nasdaq
Tenet 54 · Mixed
Compare
$55.37−0.02%At closeTenet 54 · Mixed
$55.37−0.01 (−0.02%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Axogen (AXGN) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~15.3%/yr (FY21→FY25), net margin −7.0%. Worth your attention in FY25: Share count (+11.7%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲20.2%
225.2
FY21→FY25CAGR +15.3%/yr
Net income ($M)▼57.6%
−15.7
FY21→FY25CAGR —
Free cash flow ($M)—
−2.9
FY21→FY25CAGR —
Diluted EPS▼47.8%
−0.34
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+11.7%

41.2mn → 46.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$3.7M

+20.8% YoY in FY25 · 1.7% of revenue.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)225.2Revenue−57.9COGS167.4Gross profit−32.9R&D−44.6SG&A−7.8Op income−7.9Tax & other−15.7Net income

-7¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~3%FY21FY25

Over this window: gross 82.0% → 74.3%. Net margin -7.0% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 0.7485, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
266,926.0225,208.0187,338.0159,012.0138,584.0127,358.0▲20.2%+15.3%
Cost of revenue
68,923.057,855.045,361.037,143.029,775.022,931.0▲27.5%+26.0%
Gross profit
198,003.0167,353.0141,977.0121,869.0108,809.0104,427.0▲17.9%+12.5%
Research & development
37,432.032,885.027,767.027,339.025,627.024,177.0▲18.4%+8.0%
Selling, general & admin
57,344.044,577.039,036.038,412.040,906.032,338.0▲14.2%+8.4%
Total operating expenses
211,808.0175,202.0145,264.0143,331.0138,516.0129,843.0▲20.6%+7.8%
Operating incomefeeds ROC rank
−13,805.0−7,849.0−3,287.0−21,462.0−29,707.0−25,416.0▼138.8%—
Other income, net
−18,117.0−7,854.0−6,677.0−254.0759.0−1,662.0——
Pretax income
−31,922.0−15,703.0−9,964.0−21,716.0−28,948.0−27,078.0▼57.6%—
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−31,922.0−15,703.0−9,964.0−21,716.0−28,948.0−26,985.0▼57.6%—
Per share
Diluted EPSbuyback-sensitive
−0.65−0.34−0.23−0.51−0.69−0.65▼47.8%—
Diluted shares (mn)
61.5346.0544.2642.8842.0841.21▲4.1%+2.8%
Margins
Gross margin67th pct in Healthcare
74.2%74.3%75.8%76.6%78.5%82.0%▼1.5pp−7.7pp
Operating margin
−5.2%−3.5%−1.8%−13.5%−21.4%−20.0%▼1.7pp+16.5pp
Net margin26th pct in Healthcare
−12.0%−7.0%−5.3%−13.7%−20.9%−21.2%▼1.7pp+14.2pp
† TTM = trailing four quarters through 2026-09-30.
FY10 – FY20 · 11 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 11 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Axogen's revenue last fiscal year?

Axogen reported revenue of $225.2M in fiscal 2025, up 20.2% from fiscal 2024.

What was Axogen's net income?

Axogen reported net income of −$15.7M in fiscal 2025, a net margin of −7.0%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.